Gujarat is drawing fresh pharma investment worth INR 2,500-3,000 crore. The money is going into new drug manufacturing facilities across the state. The investment follows approvals for 59 new allopathic medicine plants during FY2025-26.
Pharma exports, drug regulation, and rare disease therapies are signaling a broader shift across the pharmaceutical sector
In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Dr. Rajan Sriraman, Research & Development Vaccines Head at Reliance Life Sciences, discusses the evolution of vaccine R&D, the role of recombinant technologies an
.jpg)
Hyderabad is set for a major boost as Amgen plans a new R&D center in the city. The center will strengthen the company’s research capabilities in India. It will also expand Hyderabad’s role in global drug research and innovation.
The latest developments across drug regulation, R&D, and healthcare expansion signal important shifts in the global and Indian pharmaceutical industry
Today’s pharma news highlights major drug launches, drug approvals and financial developments across respiratory care, obesity treatment and generic medicines
The latest developments highlight CDMO deals, Q1 earnings, and AI medtech transformation as key drivers shaping the pharmaceutical sector
India’s healthcare sector saw major funding, partnerships, investments, expansion plans, and pharma developments this week. KKR moved to acquire Medicover India in a USD 1.5 billion healthcare deal. Cipla and Rocket India announced...
Clinical innovation drives a new wave of transformation as companies expand biosimilars portfolios, regulators strengthen drug quality frameworks
Skin cancer continues to challenge global healthcare systems as cases rise and treatment gaps persist. But a recent USFDA approval has introduced new hope in skin cancer treatment
.jpg)
, CDSCO.jpg)